B.C. funding rapid access treatment, public safety to address overdose crisis Health Canada’s OTC codeine ban is a Band-Aid solutionWe want to expand the scope of pharmacists to take the burden off physicians and ERs, but this ban is a move in the opposite direction Drug benefit plan managers and sponsors often overlook pharmacists At the 2017 drug benefits summit, Mark Rolnick of Shoppers Drug Mart suggested opportunities are being missed Pay incentives for doctors don't improve follow-up rates for patients discharged from hospital Pharmacists lobby Ontario to establish $75 consultation for opioid management If prescription rates remain consistent with the previous year, the program could cost upwards of $150 million Pharmacare could save Canada over $4 billion a year in drug costs A new report from the Parliamentary Budget Officer comes a year after a House of Commons Standing Committee asked for a cost estimate Tresiba (insulin degludec): third basal insulin analogue in Canada Glucose-lowering effect of ultralong-acting basal insulin lasts for more than 42 hours Health systems often discriminate against Indigenous patients: Philpott How to address the opioid crisis? Invest in 'social capital' Ontario to cover HIV prevention drug under public health plan The brand name Truvada costs about $1,000 a month but new products are hitting the market at a quarter of that cost First Previous 1077 1078 1079 1080 1081 Next Last
